Noppen Marc, Poppe Kris, D'Haese Jan, Meysman Marc, Velkeniers Brigitte, Vincken Walter
Interventional Endoscopy Clinic and Respiratory Division, Academic Hospital AZ-VUB 101, Free University of Brussels, Laarbeeklaan V, 1000 Brussels, Belgium.
Chest. 2004 Feb;125(2):723-30. doi: 10.1378/chest.125.2.723.
Surgery is the treatment of choice for symptomatic tracheal obstruction due to benign or malignant thyroid disease. In case of inoperability, or when surgery is refused, few therapeutic alternatives are available. Interventional bronchoscopic procedures have only been reported anecdotally. The objective of this study is to evaluate the results of interventional bronchoscopic procedures in the treatment of severe tracheal obstruction due to thyroid disease.
Retrospective cohort analysis.
University hospital, tertiary referral center.
Thirty consecutive patients referred for bronchoscopic treatment of benign (n = 17) or malignant (n = 13) thyroid-related upper airway obstruction due to tracheomalacia, extrinsic compression, and/or tracheal ingrowth. Indications for bronchoscopic treatment were medical or surgical inoperability, prevention or treatment of tracheomalacia, and refusal of surgery. There were no procedure-related complications.
Rigid bronchoscopy with dilatation, stenting and/or Nd-YAG laser treatment, and clinical follow-up.
Subjective improvement, pulmonary function tests, early and late complications, and survival. In the benign group, immediate (100% relief of dyspnea) and long-term (88% relief of dyspnea) results were excellent after airway stenting (21 stents used in 17 patients). There was one unrelated death 1 week after stenting in a 98-year-old patient. There were 6% and 30% short-term and long-term complications, respectively, that could be managed endoscopically. In the malignant group, Nd-YAG laser treatment (n = 3) and stenting (n = 13) yielded immediate and long-term success in 92% of patients. There were 15% short-term and 8% long-term complications. Median survival time was 540 days.
Interventional bronchoscopic procedures including Nd-YAG laser treatment and stenting are valuable alternatives to surgery in inoperable thyroid-induced tracheal obstruction, or when surgery is refused.
手术是治疗因良性或恶性甲状腺疾病导致的有症状气管阻塞的首选方法。在无法进行手术或患者拒绝手术的情况下,几乎没有其他治疗选择。介入性支气管镜检查程序仅有个案报道。本研究的目的是评估介入性支气管镜检查程序治疗因甲状腺疾病导致的严重气管阻塞的效果。
回顾性队列分析。
大学医院,三级转诊中心。
连续30例因气管软化、外部压迫和/或气管内生长导致良性(n = 17)或恶性(n = 13)甲状腺相关上气道阻塞而接受支气管镜治疗的患者。支气管镜治疗的指征为内科或外科手术无法进行、预防或治疗气管软化以及拒绝手术。没有与操作相关的并发症。
硬质支气管镜检查,包括扩张、支架置入和/或Nd-YAG激光治疗,并进行临床随访。
主观改善情况、肺功能测试、早期和晚期并发症以及生存率。在良性组中,气道支架置入后(17例患者使用了21个支架),即刻(呼吸困难缓解率100%)和长期(呼吸困难缓解率88%)效果均极佳。一名98岁患者在支架置入1周后出现一例无关死亡。分别有6%和30%的短期和长期并发症可通过内镜处理。在恶性组中,Nd-YAG激光治疗(n = 3)和支架置入(n = 13)使92%的患者获得即刻和长期成功。短期和长期并发症发生率分别为15%和8%。中位生存时间为540天。
包括Nd-YAG激光治疗和支架置入在内的介入性支气管镜检查程序,对于无法进行手术的甲状腺所致气管阻塞或患者拒绝手术的情况,是手术的有价值替代方法。